|
Aubrey de Grey (b. 1963) is a biogerontologist at the University of Cambridge in England who is currently working to expedite the development of a cure for human aging, a medical goal he refers to as engineered negligible senescence (senescence means aging). De Grey is also an outspoken supporter of radical life extension.
Prior to his work as a biologist, de Grey was formally trained in computer science and bioinformatics. He argues that the fundamental knowledge necessary to develop effective anti-aging medicine mostly exists today. To that end he works to identify and promote specific technological approaches to the reversal of various aspects of aging and for the more proactive and urgent approaches to extending the healthy human lifespan.
As of 2005, De Grey's current work at Cambridge centered around a detailed plan called Strategies for Engineered Negligible Senescence (SENS) which is aimed at preventing age-related physical and cognitive decline. He is also the co-founder and chief scientist of the Methuselah Mouse Prize, a contest designed to accelerate research into effective life extension interventions by awarding prizes to researchers who extend the lifespan of mice to unprecedented lengths. De Grey defends that once this objective has been achieved, the resulting public attention to this issue will result in more funding being applied to this kind of research, which would then bring forward more and more progresses.
External links
|
